[Thyroid orbitopathy, an overview with special attention to the role of radiotherapy]

Endocrinol Nutr. 2015 Apr;62(4):188-99. doi: 10.1016/j.endonu.2014.12.004. Epub 2015 Jan 27.
[Article in Spanish]

Abstract

Thyroid orbitopathy is the most prevalent non-thyroid symptom in Graves' syndrome. It has a high incidence and particularly affects young women. Smoking is clearly involved in its development and progress, and in its response to different treatments. This autoimmune condition usually has a benign course, independent from hyperthyroidism, but its severe, progressive forms represent a major therapeutic challenge. Clinical evaluation poses great difficulties, as there is no truly objective rating scale representing disease activity. New molecular or inflammation markers may prove to be useful in this regard. This review reports new findings about its pathophysiology and the different techniques used for treatment over time. Discussion particularly focuses on the immunomodulatory role of radiotherapy, as well as on its role together with corticosteroids.

Keywords: Corticoides; Corticosteroids; Graves ophthalmopathy; Irradiación; Irradiation; Oftalmopatía de Graves; Orbitopatía tiroidea; Radioterapia; Radiotherapy; Thyroid orbitopathy.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Combined Modality Therapy
  • Decompression, Surgical
  • Double-Blind Method
  • Female
  • Graves Ophthalmopathy / immunology
  • Graves Ophthalmopathy / physiopathology
  • Graves Ophthalmopathy / radiotherapy*
  • Graves Ophthalmopathy / therapy
  • Humans
  • Incidence
  • Male
  • Models, Biological
  • Pentoxifylline / therapeutic use
  • Radiation Injuries / etiology
  • Radiotherapy, High-Energy / adverse effects
  • Radiotherapy, High-Energy / methods
  • Randomized Controlled Trials as Topic
  • Selenium / therapeutic use
  • Smoking / adverse effects

Substances

  • Adrenal Cortex Hormones
  • Selenium
  • Pentoxifylline